Delayed
Hong Kong S.E.
01:38:20 14/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.104
HKD
|
-0.95%
|
|
+0.97%
|
+4.00%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
320
|
94.4
|
56.8
|
64
|
59.2
|
56.8
|
Enterprise Value (EV)
1 |
258.2
|
35.95
|
-15.93
|
-3.069
|
6.305
|
-2.126
|
P/E ratio
|
-82.3
x
|
14.3
x
|
5.94
x
|
8.14
x
|
14.6
x
|
7.51
x
|
Yield
|
-
|
1.06%
|
6.16%
|
5.63%
|
4.05%
|
5.63%
|
Capitalization / Revenue
|
5.96
x
|
1.63
x
|
0.84
x
|
0.91
x
|
0.82
x
|
0.74
x
|
EV / Revenue
|
4.81
x
|
0.62
x
|
-0.24
x
|
-0.04
x
|
0.09
x
|
-0.03
x
|
EV / EBITDA
|
17.4
x
|
4.15
x
|
-1.33
x
|
-0.38
x
|
0.97
x
|
-0.26
x
|
EV / FCF
|
15.8
x
|
-7.19
x
|
-0.9
x
|
-1.6
x
|
-1.29
x
|
-0.2
x
|
FCF Yield
|
6.35%
|
-13.9%
|
-111%
|
-62.6%
|
-77.7%
|
-502%
|
Price to Book
|
4.29
x
|
1.16
x
|
0.64
x
|
0.69
x
|
0.63
x
|
0.58
x
|
Nbr of stocks (in thousands)
|
8,00,000
|
8,00,000
|
8,00,000
|
8,00,000
|
8,00,000
|
8,00,000
|
Reference price
2 |
0.4000
|
0.1180
|
0.0710
|
0.0800
|
0.0740
|
0.0710
|
Announcement Date
|
28/06/18
|
27/06/19
|
29/06/20
|
25/06/21
|
24/06/22
|
26/06/23
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
53.7
|
58.04
|
67.23
|
70.24
|
71.98
|
76.7
|
EBITDA
1 |
14.84
|
8.665
|
11.99
|
8.181
|
6.533
|
8.222
|
EBIT
1 |
14.44
|
7.737
|
11.05
|
7.346
|
5.918
|
7.833
|
Operating Margin
|
26.88%
|
13.33%
|
16.44%
|
10.46%
|
8.22%
|
10.21%
|
Earnings before Tax (EBT)
1 |
-0.447
|
8.246
|
11.9
|
9.357
|
5.478
|
9.377
|
Net income
1 |
-3.08
|
6.608
|
9.566
|
7.859
|
4.048
|
7.562
|
Net margin
|
-5.74%
|
11.38%
|
14.23%
|
11.19%
|
5.62%
|
9.86%
|
EPS
2 |
-0.004862
|
0.008260
|
0.0120
|
0.009823
|
0.005060
|
0.009452
|
Free Cash Flow
1 |
16.39
|
-5.003
|
17.68
|
1.92
|
-4.901
|
10.68
|
FCF margin
|
30.52%
|
-8.62%
|
26.3%
|
2.73%
|
-6.81%
|
13.92%
|
FCF Conversion (EBITDA)
|
110.48%
|
-
|
147.46%
|
23.47%
|
-
|
129.87%
|
FCF Conversion (Net income)
|
-
|
-
|
184.84%
|
24.43%
|
-
|
141.2%
|
Dividend per Share
|
-
|
0.001250
|
0.004375
|
0.004500
|
0.003000
|
0.004000
|
Announcement Date
|
28/06/18
|
27/06/19
|
29/06/20
|
25/06/21
|
24/06/22
|
26/06/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
61.8
|
58.4
|
72.7
|
67.1
|
52.9
|
58.9
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
16.4
|
-5
|
17.7
|
1.92
|
-4.9
|
10.7
|
ROE (net income / shareholders' equity)
|
-5.82%
|
8.49%
|
11.3%
|
8.66%
|
4.34%
|
7.87%
|
ROA (Net income/ Total Assets)
|
14.6%
|
5.38%
|
7.05%
|
4.23%
|
3.33%
|
4.34%
|
Assets
1 |
-21.16
|
122.9
|
135.8
|
185.6
|
121.7
|
174.2
|
Book Value Per Share
2 |
0.0900
|
0.1000
|
0.1100
|
0.1200
|
0.1200
|
0.1200
|
Cash Flow per Share
2 |
0.0800
|
0.0700
|
0.0900
|
0.0900
|
0.0700
|
0.0800
|
Capex
1 |
1.58
|
1.5
|
0.22
|
0.39
|
0.78
|
0.06
|
Capex / Sales
|
2.95%
|
2.59%
|
0.32%
|
0.55%
|
1.09%
|
0.08%
|
Announcement Date
|
28/06/18
|
27/06/19
|
29/06/20
|
25/06/21
|
24/06/22
|
26/06/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.00% | 1.08Cr | | -3.88% | 936.44Cr | | +1.10% | 148.56Cr | | +2.65% | 143.13Cr | | -11.55% | 120.91Cr | | -16.13% | 88Cr | | +0.72% | 48Cr | | -47.14% | 37Cr | | -20.99% | 35Cr | | -2.34% | 21Cr |
Medical Equipment Wholesale
|